Trivoglitor Forte 1

TRIVOGLITOR FORTE 1

TRIVOGLITOR FORTE 1, manufactured by Torrent Pharmaceuticals Ltd, is a triple-combination oral anti-diabetic medication.

• Name

  • Brand Name: Trivoglitor Forte 1 Tablet, Trivoglitor Forte 1 Tablet SR
  • Common Name: Glimepiride + Metformin + Voglibose (Fixed-dose combination)

• Composition

  • Each tablet typically contains:
    • Glimepiride (1 mg)
    • Metformin (500 mg)
    • Voglibose (0.3 mg)

• Uses TRIVOGLITOR FORTE 1 is prescribed for the management of Type 2 Diabetes Mellitus in adults. It is particularly indicated when blood sugar levels are not adequately controlled by diet, exercise, and single or dual anti-diabetic medications alone. This combination medicine works by:

  • Glimepiride: Stimulates the pancreas to release more insulin.
  • Metformin: Reduces glucose production in the liver, delays glucose absorption from the intestines, and enhances the body's sensitivity to insulin.
  • Voglibose: Inhibits enzymes that break down complex carbohydrates in the gut, thereby slowing the absorption of glucose and reducing post-meal blood sugar spikes. It also helps to reduce the risk of serious diabetic complications such as kidney damage, blindness, nerve problems, heart attack, and stroke.

• Dosage and Administration

  • Take TRIVOGLITOR FORTE 1 exactly as prescribed by your doctor.
  • Swallow the tablet whole with a glass of water; do not chew, crush, or break it.
  • It should generally be taken with or immediately before meals, ideally at the same time each day, to maximize benefits and avoid stomach upset.
  • Do not stop taking this medicine without consulting your doctor, as abrupt discontinuation can lead to increased blood sugar levels.

• Side Effects

  • Common Side Effects: Hypoglycemia (low blood sugar levels, characterized by dizziness, sweating, hunger pangs, dry mouth, shaking, headache, irritability, fast heart rate), changes in taste, nausea, diarrhea, stomach pain/abdominal discomfort, headache, flatulence, vomiting, loss of appetite, upper respiratory symptoms, edema (swelling), blurred vision, bone fracture, and weight gain.
  • Serious Side Effects (Seek immediate medical attention if experienced): Severe hypoglycemia, lactic acidosis (symptoms include exhaustion, extreme fatigue, body weakness, diarrhea, muscle pain, breathing difficulties, unusual tiredness), or a serious skin reaction like bullous pemphigoid.

• Precautions

  • Inform your doctor if you have any pre-existing conditions such as pancreatitis, kidney disease, liver disease (it is contraindicated in severe kidney or liver disease), heart disease, or a low vitamin B12 level.
  • TRIVOGLITOR FORTE 1 is contraindicated in Type 1 Diabetes Mellitus, diabetic ketoacidosis, severe acute conditions (e.g., dehydration, severe infection, severe trauma), lung problems, heart problems (e.g., acute or chronic cardiac failure, recent myocardial infarction), and in individuals allergic to its components, other sulfonylureas, or sulphonamides.
  • Pregnancy and Breastfeeding: Not recommended during pregnancy or breastfeeding.
  • Alcohol: Avoid alcohol consumption as it can increase the risk of hypoglycemia and a rare but serious condition called lactic acidosis.
  • Drug Interactions: Inform your doctor about all other medications you are taking, including over-the-counter drugs and herbal supplements, as interactions can occur with antibacterials, antifungals, other antidiabetics, insulin, corticosteroids, diuretics, certain painkillers, and blood thinners.
  • Regular monitoring of blood sugar levels, and possibly blood cell counts and liver/thyroid function, is recommended during treatment.
  • Always carry a fast-acting source of glucose (e.g., glucose tablets, sugary food) to manage potential low blood sugar episodes.
  • Caution is advised in elderly patients. It is not recommended for children and adolescents under 18 years of age.

• Storage

  • Store in a cool and dry place, protected from direct sunlight and moisture.
  • Keep out of sight and reach of children.
  • Typically, store at temperatures between 10ºC to 25ºC or below 30ºC.

TRIVOGLITOR FORTE 1, manufactured by TORRENT PHARMACEUTICALS LTD, is a combination medicine used to manage Type 2 diabetes mellitus in adults. It contains Glimepiride, Metformin, and Voglibose, which work together to help control blood sugar levels.

What is TRIVOGLITOR FORTE 1 used for?

TRIVOGLITOR FORTE 1 is primarily used for the management of Type 2 diabetes mellitus in adults. It is particularly beneficial when diet, exercise, and single or dual anti-diabetic medications alone are not sufficient to adequately control blood sugar levels. This medication also helps prevent serious complications associated with diabetes, such as kidney damage, blindness, nerve problems, and reduces the risk of heart attack or stroke.

How does TRIVOGLITOR FORTE 1 work?

TRIVOGLITOR FORTE 1 combines three active ingredients that work in different ways to lower blood sugar levels:

• Glimepiride: This sulfonylurea stimulates the pancreatic beta cells to produce more insulin and increases the sensitivity of peripheral tissues to insulin.
• Metformin: As a biguanide, it reduces the amount of glucose produced by the liver, slows down the absorption of glucose from the intestines, and enhances the body's response to insulin, improving glucose uptake and utilization.
• Voglibose: This alpha-glucosidase inhibitor delays the breakdown of complex carbohydrates into simple sugars in the intestine, thereby reducing post-meal spikes in blood sugar levels.

What is the usual dosage for TRIVOGLITOR FORTE 1?

TRIVOGLITOR FORTE 1 should be taken exactly as prescribed by your doctor. The dosage may vary based on your individual health condition and how your body responds to the medicine. It is generally recommended to take this medication with or immediately before meals, preferably with breakfast. The tablet should be swallowed whole with a glass of water and not broken, crushed, or chewed.

What are the possible side effects of TRIVOGLITOR FORTE 1?

Common side effects may include low blood sugar levels (hypoglycemia), diarrhea, flatulence (excessive gas), abdominal discomfort or pain, nausea, vomiting, metallic taste, loss of appetite, headache, taste changes, and upper respiratory symptoms. Some individuals might also experience blurred vision, edema (swelling), bone fracture, or weight gain due to the glimepiride component. In rare cases, a serious condition called lactic acidosis may occur, indicated by symptoms such as exhaustion, extreme fatigue, body weakness, diarrhea, and headache.

Is TRIVOGLITOR FORTE 1 safe during pregnancy or breastfeeding?

TRIVOGLITOR FORTE 1 is generally not recommended and is contraindicated during pregnancy, as it may cause harm to the fetus. Similarly, it is not recommended for breastfeeding women, as the medicine may pass through breast milk and potentially harm the nursing child. Always consult your doctor if you are pregnant, planning to conceive, or breastfeeding.

Can TRIVOGLITOR FORTE 1 be taken with other medications?

TRIVOGLITOR FORTE 1 can interact with several other medications. For instance, corticosteroids and diuretics may increase blood glucose levels, reducing its effectiveness. Other medicines like oral contraceptives, rifampicin, phenytoin, and thyroid disorder medications can also affect blood glucose levels. It may also alter the way blood thinners, such as phenprocoumon, work. Combining it with other anti-diabetics or insulin requires caution due to an increased risk of hypoglycemia. It is crucial to inform your doctor about all medicines you are taking, including prescribed, non-prescribed, herbal medicines, and dietary supplements.

What precautions should be taken while using TRIVOGLITOR FORTE 1?

You should avoid TRIVOGLITOR FORTE 1 if you are allergic to glimepiride, metformin, voglibose, or any other sulfonylureas or sulphonamides. It is contraindicated in patients with Type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, metabolic acidosis, certain heart conditions (like shock or heart failure), severe infection, and alcoholism. Use with caution in patients with mild to moderate liver or kidney issues and in elderly patients. Alcohol consumption should be avoided as it can cause an imbalance in blood sugar levels and increase the risk of lactic acidosis. Regular monitoring of blood sugar levels is essential, and your doctor may recommend periodic blood tests to check kidney and liver function. Always carry a fast-acting source of sugar to manage potential hypoglycemia. Do not stop taking the medicine without consulting your doctor, as this can lead to an increase in blood sugar levels and associated complications.

What happens if a dose of TRIVOGLITOR FORTE 1 is missed?

If you miss a dose of TRIVOGLITOR FORTE 1, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed one and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one. It's important not to alter your dosage without consulting your doctor first.

How should TRIVOGLITOR FORTE 1 be stored?

TRIVOGLITOR FORTE 1 should be stored in a cool, dry place, ideally below 25°C. Keep the medicine protected from light and moisture. Always ensure it is kept out of reach of children. Remember to use the medicine before the expiry date mentioned on the product packaging.